Skip to main content
. Author manuscript; available in PMC: 2015 Aug 17.
Published in final edited form as: Ann Intern Med. 2015 Feb 17;162(4):266–275. doi: 10.7326/M14-1281

Table 4.

Predicted and Observed Events for Each Risk Score in Clinically Relevant Risk Categories: Women

Risk Score, % Participants, n Predicted Events, n (%) Observed Events, n (%) Signed Absolute Difference Discordance, %* Hosmer–Lemeshow Chi-Square Statistic
FRS-CHD

 0.0–4.9 963 32.2 (3.3) 29 (3.0) 0.3 11 0.33

 5.0–7.4 594 36.3 (6.1) 26 (4.4) 1.7 40 3.13

 7.5–9.9 343 29.5 (8.6) 16 (4.7) 3.9 85 6.78

 ≥10.0 366 48.5 (13.2) 28 (7.7) 5.6 73 9.98

 Total 2266 146.5 (6.5) 99 (4.4) 2.1 48 20.21

FRS-CVD
 0.0–4.9 724 22.9 (3.2) 19 (2.6) 0.5 20 0.68

 5.0–7.4 477 29.3 (6.1) 25 (5.2) 0.9 18 0.67

 7.5–9.9 325 28.1 (8.6) 28 (8.6) 0.0 0 0.00

 ≥10.0 740 122.3 (16.5) 115 (15.5) 1.0 6 0.52

 Total 2266 202.6 (8.9) 187 (8.3) 0.7 8 1.87
ATPIII-FRS-CHD

 0.0–4.9 1836 35.0 (1.9) 29 (1.6) 0.3 21 1.05

 5.0–7.4 235 14.2 (6.0) 8 (3.4) 2.6 77 2.84

 7.5–9.9 109 9.3 (8.6) 5 (4.6) 4.0 87 2.21

 ≥10.0 86 11.7 (13.6) 6 (7.0) 6.6 94 3.18

 Total 2266 70.2 (3.1) 48 (2.1) 1.0 46 9.29

RRS
 0.0–4.9 1608 33.2 (2.1) 55 (3.4) −1.3 −40 14.60

 5.0–7.4 262 16.0 (6.1) 16 (6.1) 0.0 0 0.00

 7.5–9.9 158 13.7 (8.7) 16 (10.1) −1.5 −15 0.43

 ≥10.0 238 37.6 (15.8) 40 (16.8) −1.0 −6 0.18

 Total 2266 100.5 (4.4) 127 (5.6) −1.2 −21 15.21
AHA-ACC-ASCVD

 0.0–4.9 1140 27.4 (2.4) 19 (1.7) 0.7 44 2.64

 5.0–7.4 355 21.8 (6.1) 16 (4.5) 1.6 36 1.65

 7.5–9.9 235 20.5 (8.7) 12 (5.1) 3.6 71 3.86

 ≥10.0 536 85.4 (15.9) 46 (8.6) 7.3 86 21.60

 Total 2266 155.1 (6.8) 93 (4.1) 2.7 67 29.75

ACC = American College of Cardiology; AHA = American Heart Association; ASCVD = atherosclerotic cardiovascular disease; ATPIII = Adult Treatment Panel III; CHD = coronary heart disease; CVD = cardiovascular disease; FRS = Framingham risk score; RRS = Reynolds Risk Score.

*

Percentage discordance calculation: ([{expected percentage − observed percentage}/observed percentage] × 100).

HHS Vulnerability Disclosure